From Molecular Classification to Targeted Therapeutics: The Changing Face of Systemic Therapy in Metastatic Gastroesophageal Cancer
Histological classification of adenocarcinoma or squamous cell carcinoma for esophageal cancer or using the Lauren classification for intestinal and diffuse type gastric cancer has limited clinical utility in the management of advanced disease. Germline mutations in E-cadherin (CDH1) or mismatch rep...
Saved in:
| Main Authors: | Adrian Murphy, Ronan J. Kelly |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2015/896560 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Unusual Course of Metastatic Gastroesophageal Cancer
by: William H. Smith, et al.
Published: (2015-01-01) -
Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers
by: Whi-An Kwon, et al.
Published: (2025-04-01) -
Breath- and blood-based molecular assessment for gastroesophageal cancer
by: S. Vanstraelen, et al.
Published: (2025-03-01) -
Editorial: Molecular mechanisms and therapeutic targets of cancer metastasis and therapy resistance
by: Ya-Wen Wang, et al.
Published: (2025-03-01) -
Editorial: DNA methylation in cancer therapy: therapeutic targets and molecular mechanism
by: Guoyi Yan, et al.
Published: (2024-12-01)